CVS Health Corporation
 (CVS)

- NYSE
What's your position on ?
Bullish
Bearish
Why are you ish?
Skip
Post
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Last vote:
  • May 21, 2015, 7:32 AM
    • CVS Health (NYSE:CVS) confirms it will acquire Omnicare (NYSE:OCR) for $98 per share in a deal valued at $12.7B.
    • The transaction is expected to close near the end of the year.
    • The company sees the purchase adding $0.20 to EPS in 2016
    • Previously: Bloomberg: CVS in advanced talks to buy Omnicare
    • OCR +1.39% premarket to $95.95.
    • CVS +1.77% premarket to $103.06.
    | May 21, 2015, 7:32 AM | 3 Comments
  • May 20, 2015, 6:15 PM
    • CVS is in advanced talks to buy nursing home pharmacy owner Omnicare (NYSE:OCR) and could reach a deal as soon as this week, sources tell Bloomberg.
    • Omnicare hired advisors to find a buyer earlier this year. In April, Bloomberg reported CVS was one of several interested parties.
    • OCR +5.7% AH to $100.00. CVS +0.5% to $101.80.
    | May 20, 2015, 6:15 PM | 5 Comments
  • May 13, 2015, 12:22 PM
    • CVS Health (CVS -0.5%) settles the case brought by the U.S. Attorney's Office for the Middle District of Florida and the U.S. Drug Enforcement Administration (DEA) concerning allegations related to the over-dispensing of oxycodone by two CVS stores in Sanford, Florida. The company agreed to pay $22M to resolve the matter.
    • In 2012, the DEA banned the two pharmacies from selling controlled drugs calling them an "imminent danger" to the public. The average pharmacy in the U.S. ordered ~69K oxycodone pills from wholesalers in 2011. The two pharmacies in question, located about five miles apart, ordered more than 3M.
    | May 13, 2015, 12:22 PM | 1 Comment
  • May 1, 2015, 8:59 AM
    • CVS Health (NYSE:CVS) Q1 results ($M): Total Revenues: 36,332 (+11.1%); Net Income: 1,221 (+8.1%); GAAP EPS: 1.07 (+12.6%); Non-GAAP EPS: 1.14 (+11.8%); Quick Assets: 1,634 (-35.0%); CF Ops: 1,984 (-8.7%); 
    • Retail Pharmacy revenue up 2.9% to $16.95B.
    • Retail Pharmacy same-store sales up 1.2%.
    • Retail Pharmacy same-store prescription volumes up 5.1%.
    • Generic dispensing rate: Pharmacy services: 83.5% (+150 bps); Retail Pharmacy: 84.4% (+150 bps).
    • Gross margin rate down 121 bps to 16.97%.
    • Operating margin rate down 32 bps to 5.87%.
    • FY2015 Guidance: GAAP EPS: $4.80 to $4.91; Non-GAAP EPS: $5.08 to $5.19; CF Ops: $7.6B to $7.9B.
    • Q2 Guidance: GAAP EPS: $1.10 to $1.13; Non-GAAP EPS: $1.17 to $1.20. 
    • Shares up 2% premarket on light volume.
    | May 1, 2015, 8:59 AM
  • May 1, 2015, 7:01 AM
    • CVS Health (NYSE:CVS): Q1 EPS of $1.14 beats by $0.06.
    • Revenue of $36.33B (+11.1% Y/Y) beats by $400M.
    | May 1, 2015, 7:01 AM | 14 Comments
  • Apr. 30, 2015, 5:30 PM
    | Apr. 30, 2015, 5:30 PM | 5 Comments
  • Apr. 30, 2015, 4:08 PM
    | Apr. 30, 2015, 4:08 PM | 2 Comments
  • Mar. 31, 2015, 8:46 AM
    • CVS Health (NYSE:CVS) announces new affiliations with medical centers in Illinois and Arizona.
    • The company signed a clinical deal with Rush University Medical Center in Chicago and Tucson Medical Center in Tucson.
    • CVS says it now has more than 50 major health systems and providers in its system.
    | Mar. 31, 2015, 8:46 AM | 9 Comments
  • Mar. 4, 2015, 10:48 AM
    • CVS Health (NYSE:CVS) declares $0.35/share quarterly dividend, in line with previous.
    • Forward yield 1.36%
    • Payable May 4; for shareholders of record April 24; ex-div April 22.
    | Mar. 4, 2015, 10:48 AM
  • Feb. 12, 2015, 9:43 AM
    | Feb. 12, 2015, 9:43 AM | 3 Comments
  • Feb. 11, 2015, 9:30 AM
    • Investment firms are resetting expectations on CVS Health (NYSE:CVS) after taking in the drugstore chain's Q4 report.
    • Argus raises its price target on CVS to $114 from $104.
    • RBC Capital increases its PT to $115 from $108.
    • Mizuho is also erasing its PT, moving it to $113 from $103.
    • Previously: Margins improve at CVS Health in Q4 (Feb. 10 2015)
    • CVS -0.2% premarket to $101.45.
    | Feb. 11, 2015, 9:30 AM | 5 Comments
  • Feb. 10, 2015, 7:18 AM
    • CVS Health (NYSE:CVS) reports revenue in its pharmacy segment rose 21.7% to $23.9B in Q4 with acquisition playing a factor.
    • Pharmacy network claims processed rose 8.2% to 221.6M during the period.
    • Retail pharmacy sales +2.9% to $17.7B.
    • Retail comparable-store sales +1.6% with the front end store comp dragged down by the tobacco exit.
    • Gross profit rate +70 bps to 31.4%.
    • Operating profit rate +40 bps to 10.1%.
    • CVS +1.85% premarket.
    | Feb. 10, 2015, 7:18 AM
  • Feb. 10, 2015, 7:04 AM
    • CVS Health (NYSE:CVS): Q4 EPS of $1.21 beats by $0.01.
    • Revenue of $37.06B (+12.9% Y/Y) beats by $980M.
    | Feb. 10, 2015, 7:04 AM
  • Feb. 9, 2015, 5:30 PM
    | Feb. 9, 2015, 5:30 PM | 6 Comments
  • Feb. 5, 2015, 1:36 PM
    • CVS Health (CVS -0.3%) says its pharmacists have counseled over 67K patients about their smoking habits since pulling out of the category last September.
    • Prescriptions for smoke cessation products are up 63% during the period.
    • Sales of nicotine replacement therapy products are up 21%.
    • Shares of CVS are up 22% since the company's tobacco exit.
    | Feb. 5, 2015, 1:36 PM | 15 Comments
  • Jan. 28, 2015, 8:40 AM
    • CVS Health (NYSE:CVS) announces new affiliations with regional health care systems in Kansas and Louisiana.
    • The agreements will increase the scope of medical services provided at CVS stores in the two states.
    • Front-end comps at CVS are still impacted by the full tobacco exit, but are seeing a benefit from the influx of new healthcare customers.
    | Jan. 28, 2015, 8:40 AM | 4 Comments
Company Description
CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.
Sector: Healthcare
Industry: Drug Stores
Country: United States